<SEC-DOCUMENT>0001013594-17-000189-index.html : 20170214 <SEC-HEADER>0001013594-17-000189.hdr.sgml : 20170214 <ACCEPTANCE-DATETIME>20170214173823 ACCESSION NUMBER: 0001013594-17-000189 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20170214 DATE AS OF CHANGE: 20170214 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Sarepta Therapeutics, Inc. CENTRAL INDEX KEY: 0000873303 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 930797222 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-54847 FILM NUMBER: 17611019 BUSINESS ADDRESS: STREET 1: 215 FIRST STREET STREET 2: SUITE 415 CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-274-4000 MAIL ADDRESS: STREET 1: 215 FIRST STREET STREET 2: SUITE 415 CITY: CAMBRIDGE STATE: MA ZIP: 02142 FORMER COMPANY: FORMER CONFORMED NAME: Sarepta Therapuetics, Inc. DATE OF NAME CHANGE: 20120712 FORMER COMPANY: FORMER CONFORMED NAME: AVI BIOPHARMA INC DATE OF NAME CHANGE: 19980930 FORMER COMPANY: FORMER CONFORMED NAME: ANTIVIRALS INC DATE OF NAME CHANGE: 19970123 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Tourbillon Capital Partners, L.P. CENTRAL INDEX KEY: 0001592476 IRS NUMBER: 460724833 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: 888 SEVENTH AVENUE STREET 2: 32ND FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 BUSINESS PHONE: 212-554-2500 MAIL ADDRESS: STREET 1: 888 SEVENTH AVENUE STREET 2: 32ND FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 FORMER COMPANY: FORMER CONFORMED NAME: Tourbillon Capital Partners LP DATE OF NAME CHANGE: 20131120 </SEC-HEADER> <DOCUMENT> <TYPE>SC 13G/A <SEQUENCE>1 <FILENAME>sarepta13ga-021417.htm <DESCRIPTION>FEBRUARY 14, 2017 <TEXT> Document 1 - file: sarepta13ga-021417.htm
</DOCUMENT> </SEC-DOCUMENT>